Germany vs Spain: HIV/AIDS deaths averted by antiretroviral therapy
Germany
2,906 deaths
in 2024
Spain
3,213 deaths
in 2024
Germany rank
51st
Spain rank
48th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Germany
- Spain
How they compare
Spain currently reports 3,213 deaths against 2,906 deaths in Germany, a difference of 307 deaths.
That makes Spain's figure about 1.1 times Germany's.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Spain ahead.
Germany ranks 51st and Spain ranks 48th of 157 countries.
Spain has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Germany | Spain | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 1,195 deaths | 1,429 deaths | 233.23 deaths | Spain |
| 2000s | 2,173 deaths | 5,789 deaths | 3,616 deaths | Spain |
| 2010s | 2,484 deaths | 4,277 deaths | 1,794 deaths | Spain |
| 2020s | 2,825 deaths | 3,345 deaths | 519.6 deaths | Spain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Germany or Spain?
- Spain, at 3,213 deaths against 2,906 deaths in Germany as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Germany and Spain?
- 307 deaths, with Spain ahead.
- How many years of comparable data are there for Germany and Spain?
- 35 years are reported by both, from 1990 to 2024.
- How do Germany and Spain rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Germany ranks 51st and Spain ranks 48th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.